Skip to main content
    M

    Molina Healthcare Inc (MOH)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $221.32
    -11.77 (-5.05%)

    Market Cap: $12.17B

    Last updated: Nov 17, 2026 at 4:38 PM ET

    Molina Healthcare Inc (MOH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Molina Healthcare (MOH) has a market cap of $12.17B and an enterprise value of $11.46B. Its trailing P/E of 110.7x is above its 10-year median of 15.8x. Its return on invested capital of 2.17% compares with a 8.99% median across 9 similar companies.

    Total Valuation

    Enterprise value is 5.82% below the market cap, as cash exceeds debt.

    Market Cap$12.17B
    Enterprise Value$11.46B
    Latest price (Nov 17, 2026)$221.32

    Key Dates

    The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 3, 2027 (expected)
    Last Earnings DateOct 21, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and shrank 4.47% a year over 2 years.

    Shares Outstanding52.20M
    Shares Change (YoY)+1.56%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)-4.47%

    Valuation Ratios

    Sales and book value multiples are 0.3x and 2.8x. Its year-end P/E ranged from 11.1x to 110.7x from 2016 to 2025.

    P/E Ratio110.7x
    Forward P/E41.5x
    P/S Ratio0.3x
    Forward P/S0.3x
    P/B Ratio2.8x
    P/TBV Ratio5.5x
    P/FCF Ratio49.0x
    P/OCF Ratio36.8x
    PEG Ratio11.8

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 32.6x EBITDA and 46.0x free cash flow.

    EV / Sales0.3x
    EV / EBITDA32.6x
    EV / EBIT66.6x
    EV / FCF46.0x

    Price Statistics

    The stock is up 60.91% over 52 weeks and trades 8.64% above its 50-day average.

    Beta (1Y)-0.05
    52-Week Change+60.91%
    1-Month Change+5.29%
    3-Month Change+10.02%
    6-Month Change+20.03%
    5-Year Change-30.75%
    10-Year Change+276.36%
    Total Return (1Y)+60.91%
    Total Return (3Y CAGR)-14.43%
    Total Return (5Y CAGR)-6.34%
    Return vs SPY (1Y)+45.19%
    Max Drawdown (1Y)-39.25%
    Max Drawdown (3Y)-70.76%
    Sharpe Ratio (1Y)0.84
    Correlation with SPY (1Y)-0.01
    50-Day Average$203.72
    200-Day Average$186.26
    52-Week Range$121.06 to $244.89
    RSI (14 Days)57.3
    Average Volume (20 Days)1.04M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.69x current liabilities, and total debt is 0.91x shareholder equity.

    Current Ratio1.69x
    Quick Ratio1.69x
    Debt / Equity0.91x
    Debt / EBITDA11.32x
    Debt / FCF15.98x
    Interest Coverage0.81x

    Returns and Efficiency

    Return on invested capital is 2.17% over the last 12 months, against a 5-year average of 7.99%.

    Return on Equity (ROE)-1.16%
    Return on Assets (ROA)-0.31%
    Return on Invested Capital (ROIC)2.17%
    Return on Capital Employed (ROCE)2.08%
    ROE (5Y Average)23.10%
    ROA (5Y Average)5.95%
    ROIC (5Y Average)7.99%
    Asset Turnover2.82x
    Receivables Turnover12.90x

    Scores

    MOH has an Altman Z-Score of 4.18, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score4.18
    Altman Z ZoneSafe
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $44.13B over the last 12 months is down 0.95% from the 12 months before.

    Revenue$44.13B
    Revenue Growth (YoY)-0.95%
    Gross Profit$5.56B
    Operating Income$172.00M
    Pretax Income-$41.00M
    Net Income-$48.00M
    EBITDA$333.00M
    EBIT$172.00M
    Reported EPS (TTM)$2.00

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 26.58% of the $15.65B in total assets.

    Cash and Equivalents$4.48B
    Total Debt$3.77B
    Net Cash$708.00M
    Net Cash Per Share$13.56
    Working Capital$5.12B
    Shareholder Equity$4.16B
    Book Value Per Share$79.60
    Tangible Book Value$2.08B
    Tangible Book Per Share$39.89
    Total Assets$15.65B
    Total Liabilities$11.50B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $95.00M of capital spending, operating cash flow left $236.00M of free cash flow.

    Operating Cash Flow$331.00M
    Capital Expenditures$95.00M
    Free Cash Flow$236.00M
    FCF Per Share$4.54
    Depreciation and Amortization$161.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 0.39%, against a 5-year average of 3.58%.

    Gross Margin12.60%
    Operating Margin0.39%
    Pretax Margin-0.09%
    Net Margin-0.11%
    EBITDA Margin0.75%
    EBIT Margin0.39%
    FCF Margin0.53%
    Gross Margin (5Y Average)14.78%
    Operating Margin (5Y Average)3.58%
    Net Margin (5Y Average)2.40%

    Growth

    Revenue grew 12.42% a year over 3 years, and EPS fell 15.91% a year.

    Revenue Growth (3Y CAGR)+12.42%
    Revenue Growth (5Y CAGR)+18.52%
    EPS Growth (3Y CAGR)-15.91%
    EPS Growth (5Y CAGR)-5.93%
    Operating Income Growth (3Y CAGR)-12.68%
    Book Value Per Share Growth (2Y CAGR)+5.17%
    Tangible Book Per Share Growth (2Y CAGR)-11.89%

    Revenue and profit by year

    Dividends and Yields

    MOH does not pay a dividend. Its free cash flow yield is 2.04%.

    Earnings Yield0.90%
    FCF Yield2.04%
    Buyback Yield0.00%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 3-for-2 forward split on May 23, 2011.

    Last Split DateMay 23, 2011
    Split TypeForward split
    Split Ratio3:2

    Peer Position

    Against 12 similar companies, MOH has the 2nd highest P/E and the 11th highest P/S.

    P/E Ratio110.7x vs 16.7x median
    P/S Ratio0.3x vs 0.5x median
    ROIC2.17% vs 8.99% median
    Revenue Growth (Trailing 4 Quarters, YoY)-0.95% vs +8.85% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 2.40% and EPS growth at -5.37% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+2.40%
    EPS Growth Forecast (2Y CAGR)-5.37%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MOH

    What is MOH's market cap?

    Molina Healthcare has a market cap of $12.17B. Its enterprise value, which adds debt and subtracts cash, is $11.46B.

    What is MOH's P/E ratio?

    Molina Healthcare has a trailing P/E ratio of 110.7x and a forward P/E of 41.5x.

    How many shares of MOH are outstanding?

    Molina Healthcare has 52.20M shares outstanding. The count is up 1.56% from a year earlier.

    Does MOH pay a dividend?

    No. Molina Healthcare does not pay a dividend.

    How much debt does MOH have?

    Molina Healthcare has $3.77B of total debt and $4.48B of cash and equivalents, a net cash position of $708.00M.